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The neuroprotective eﬀects of 3,6 -disinapoyl sucrose (DISS) from Radix Polygala against glutamate-induced SH-SY5Y neuronal
cellsinjurywereevaluatedinthepresentstudy.SH-SY5Yneuronalcellswerepretreatedwithglutamate(8mM)for30minfollowed
by cotreatment with DISS for 12h. Cell viability was determined by (3,4,5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium
bromide (MTT) assay, and apoptosis was conﬁrmed by cell morphology and ﬂow cytometry assay, evaluated with propidium
iodide dye. Treatment with DISS (0.6, 6, and 60μmol/L) increased cell viability dose dependently, inhibited LDH release, and
attenuated apoptosis. The mechanisms by which DISS protected neuron cells from glutamate-induced excitotoxicity included the
downregulation of proapoptotic gene Bax and the upregulation of antiapoptotic gene Bcl-2. The present ﬁndings indicated that
DISS exerts neuroprotective eﬀects against glutamate toxicity, which might be of importance and contribute to its clinical eﬃcacy
for the treatment of neurodegenerative diseases.
1.Introduction
Although neurological insults are diverse in nature, there are
common mechanisms of cell injury, and glutamate toxicity
playsanintegralroleinavarietyofneurobiologyofdisorders
such as Parkinson’s disease, Alzheimer’s disease, epilepsy
ischemic stroke, anxiety, and depression [1, 2]. Glutamate is
themajorfastexcitatoryneurotransmitterinthemammalian
central nerve system. Thus far, a distinct glutamate-induced
cell death pathway has been identiﬁed. The excitotoxic
pathway relies on hyperactivation of glutamate receptors
[3]. Besides, it has been proposed that the combination
of antidepressant drugs that elevate the noradrenergic neu-
rotransmission with drugs that modify the glutamatergic
system could be an option in treating depression [4].
3,6 -disinapoyl sucrose (DISS, Figure 1(a)) is the active
oligosaccharide ester component found in the root of
Polygala tenuifolia Willd (Radix Polygala). Recorded as
“YuanZhi” in the Pharmacopoeia of the People’s Republic
of China, the root has been used in traditional medicine
as, among other things, an expectorant, tonic, tranquillizer,
and antipsychotic agent. Results from previous studies
indicated that DISS had notable antidepressant eﬀects in
pharmacologicaldepressionmodels,anactioncloselyrelated
to the potentiation of central 5-hydroxytryptamine (5-HT)
and norepinephrine (NE) systems [5]. Our recent study also
found that DISS increased expression in the hippocampus
of three noradrenergic-regulated plasticity genes (laminin,
CAM-L1, and CREB) and one neurotrophic factor (BDNF)
[6]. Based on our results, we hypothesized that DISS might
have neuroprotective property. Thus, the authors used the
human neuroblastoma SH-SY5Y cell line, with a low degree
of diﬀerentiation and metabotropic glutamate receptors [7],
utilized glutamate as an insult to induce SH-SY5Y neuronal2 Journal of Biomedicine and Biotechnology
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Figure 1: Protective eﬀects of DISS on glutamate- (Glu-) induced cytotoxicity in SH-SY5Y cells. (a) Chemical structure of 3,6 -disinapoyl
sucrose (DISS). (b) Eﬀects of DISS treatment on SH-SY5Y cells viability decrease induced by glutamate (8mM) exposure. (c) Eﬀects of DISS
treatment on lactate dehydrogenase (LDH) release of SH-SY5Y cell damaged by glutamate. (d) Eﬀect of DISS on glutamate- (Glu-)induced
morphological alterations in SH-SY5Y cells. All data were expressed as mean ± S.D. of three experiments. ##P<0.01, compared with normal
cultures; ∗P<0.05, ∗∗P<0.01 compared with Glu alone group. Co: Control; Des: desipramine, which is positive drug.
cell injury, and aimed to investigate the neuroprotective
eﬀects of DISS on glutamate-induced apoptosis as well as its
mechanisms.
2. Resource and Preparation of DISS
DISS, used in present study, with a purity of over 90%,
was extracted from the roots of P. tenuifolia, which were
purchased from Traditional Chinese Medicinal (TCM) phar-
macy, Chinese People’s Liberation Army (PLA) General
Hospital (Beijing, China); a voucher specimen (NU-80617)
was deposited in the Herbarium there. Three-month air-
dried roots (965.27g) were extracted with 60% EtOH (8:1)
at room temperature for 2 weeks. The dry extract obtained
was then subjected to open column chromatography (CC)
packed with macroporous resin (1300 Version). The 50%
aqueous-ethanol fraction was concentrated under reduced
pressure using a rotary evaporator and lyophilized into
powders, further chromatographed on the silica gel column,
and eluted by CHCl3–MeOH–H2O to get DISS [8]. The
structures were identiﬁed by a combination of spectral
methods (UV, IR, MS, and NMR), with purity of over 90%.
2.1. Cell Culture and Treatment. The human neuroblastoma
SH-SY5Y was provided by Department of Obstetrics and
Gynecology in Chinese PLA General Hospital. The human
neuroblastomaSH-SY5YcellsweremaintainedinDulbecco’s
Modiﬁed Eagle Medium (DMEM) supplemented with 10%
fetal calf serum, 100U/mL penicillin, and 100U/mL strep-
tomycin in a humid atmosphere of 5% CO2 and 95% air
at 37◦C. SH-SY5Y cells were plated in plates. Conﬂuent
SH-SY5Y cells were washed twice with D-Hanks solution
before the addition of 0.25% trypsin-EDTA. The ﬂask was
left for 2-3min at room temperature(close to 20◦C), after
which the cells were detached, resuspended in full medium,
counted, and seeded into 96-well plates at a density ofJournal of Biomedicine and Biotechnology 3
1 × 104 cells/well in normal growth medium. After 24h,
the cells were completely attached to the well bottom. Then
cells were exposed to L-Glutamate (Glu) for 0.5h, followed
by treatment with various concentrations of DISSs (0.6, 6,
and 60μmol/L) and desipramine as a positive drug. DISS
and glutamate were dissolved in dimethyl sulfoxide (DMSO)
beforeaddedincell.Finaldrugconcentrationswereobtained
by dilution of stock solutions in experimental media. Final
concentrations of DMSO were always less than 0.01%, which
wasprovedtohavenoeﬀectsoncellviability.Theabsorbance
was read at 570nm with DMSO as the blank. The DISS
dose range was chosen from previous results on preliminary
experiments. Cell viability and LDH activity were measured
after 12h incubation at 37◦C.
2.2. Cell Viability. Cell viability was evaluated with the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bro-
mide (MTT) assay [9]. Brieﬂy, after 0.5h exposure to Glu,
20μLof MTT(2mg/mL in PBS) wereadded to each welland
the cells were incubated at 37◦C for 4h. The supernatants
wereaspiratedcarefully,150μLo fDMSOw e r eadd edt oeac h
welltodissolvetheprecipitate,andabsorbancewasmeasured
at 570nm using a microplate reader (Spectra MR, Dynex,
USA). Cell death was determined by measuring the lactate
dehydrogenase (LDH) activity using commercially available
kits from the Nanjing Jiancheng Bio-company (Nanjing,
China).
2.3. Flow Cytometric Detection of Apoptotic Cells. After
treatment, 5 × 106 cells were trypsinized, washed in PBS,
and centrifuged at 1000g for 5min. Then cells were ﬁxed
in 70% ethanol overnight. The pellet was rinsed twice and
resuspended in 0.5mL PBS (containing 50μg/mL RNaseA),
incubated for 30min at 37◦C. PI (50μg/mL) was added,
mixed gently, and incubated for 30min at 4◦Ci nd a r k .T h e
sampleswerethenreadinaBectonDickinsonﬂowcytometer
(USA) at 488nm excitation. A 600nm bandpass ﬁlter for PI
detection was used. Ten thousand cells in each sample were
analyzed, and the percentage of apoptotic cells accumulating
in the sub-G1 peak was calculated by CellQuest software.
2.4. Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR). Total RNA was extracted from cells cultured in the
25cm2 plastic ﬂasks with 5 × 106 cells using Trizol reagent
(Gibco BRL) as described by the manufacturer. And its
reverse transcribtion to cDNA was performed using iScript
cDNA Synthesis Kit (Bio-Rad, Calif, USA), according to
the manufacturer’s protocol. Human β-actin, bcl-2, and Bax
primers were synthesized by BM (Biomed, China) accord-
ing to the following sequences [10]. β-actin: forward 5 -
GGACATCCGCAAAGACCTGTA-3 , reverse 5 -ACATCT-
GCTGGAAGGTGGACA-3 ; bcl-2: forward 5 -TTTGAG-
TTCGGTGGGGTCATC-3 , reverse 5 -CCAGGAGA-AAT-
CAAACAGAGG-3 ;b a x :f o r w a r d5  -TTTGCTTCAGGG-
TTTCATCC- 3 , reverse 5 -GCCACTCGGAAAAAGACC-
TC-3 . SsoFast EvaGreen Supermix (Bio-Rad, Calif, USA)
was used for real-time PCR to detect abundance of PCR
products among samples. Standard curves were generated
for each gene, and transcript values were calculated relative
to dilution series of cDNA as described in Bio-Rad iQ5
System (Calif, USA). Target quantities were normalized to
18S ribosomal RNA, calibrated using control values, and
deﬁned as a value of “1.0”. All quantities were expressed as
n-fold relative to the calibrator (control).
2.5. Statistical Analysis. Data are presented as the mean ±
S.D. Statistical comparisons were made by one-way ANOVA
followed by Tukey’s post hoc test. Values of P<0.05 and
P<0.01 were considered signiﬁcant.
3. Result
3.1. Eﬀe c to fD I S So nC e l lV i a b i l i t ya n dL D HR e l e a s e .As
shown in Figures 1(b) and 1(c), 8mM of Glu was used
to induce SH-SY5Y cell injury, whose group was only
67.28 ± 1.2% viable cells and increased the LDH level
as compared to control cells, while treating the cells with
DISS at diﬀerent concentrations (0.6, 6, and 60μmol/L)
increased the viability of cells and inhibited LDH release,
both with dose-dependent. Moreover the eﬀects of DISS
could also be conﬁrmed by the morphological observation
(Figure 1(d)). There was a signiﬁcant injury in SH-SY5Y
cells after treatment with Glu, including the disappearance
of cellular processes, decrease of the refraction, and falling
to pieces. The damage in groups of DISS-treated cells was
greatly decreased.
3.2. Flow Cytometry Assay. The nuclear staining assay was
used to evaluate the morphological changes of apoptosis
in SH-SY5Y cells. As shown in Figure 2, control cells with-
out the treatment with Glu exhibited uniformly dispersed
chromatin and intact cell membrane. The cells, treated with
8mM Glu, increased the percentage of apoptotic cells from
0.96% to 4.93%, compared to control cells. However, in 0.6,
6, and 60μmol/L DISS-treated cells, cell apoptosis induced
by Glu was markedly decreased to 2.58%, 2.36%, and 1.95%,
respectively.
3.3. Eﬀect of DISS on the Expression of Bcl-2 and Bax and
in Glu-Induced Cells. The eﬀects of DISS on the expression
of the apoptotic genes Bax and Bcl-2 were also examined
in Glu-injured SH-SY5Y cells. As shown in Table 1,G l u
enhanced2-foldexpressionofBaxincreased,onthecontrary,
it decreased the levels of Bcl-2 comparison with the normal
control group. However, DISS (60μmol/L) treatment inhib-
itedtheincreaseofBaxandthedecreaseofBcl-2dramatically
at 12h of glutamate exposure.
4. Discussion
Glutamate, a major excitatory amino acid neurotransmitter
in central nervous system, mediates several physiological
processes. An increasing body of evidence indicates the
important role of the glutamatergic system in the patho-
physiology of depression. Firstly, depressed patients exhibit
elevated levels of glutamate both in plasma and the limbic4 Journal of Biomedicine and Biotechnology
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Figure 2: Eﬀect of DISS against glutamate- (Glu-) induced neurotoxicity in cultured SH-SY5Y cells by ﬂow cytometric DNA analysis. The
sub-G1 peaks were determined by ﬂow cytometry. (a) Control, (b) Glu alone, (c) Glu + 0.6μmol/L DISS, (d) Glu + 6μmol/L DISS, (e) Glu
+6 0μmol/L M DISS. Bar(|—|) represents a sub-G1 or hypodiploid DNA fraction.
Table 1: Eﬀect of DISS on Bax and Bcl-2 expression in SH-SY5Y cells after Glu exposure. β-actin was used as an internal control. Results are
from three independent experiments.
Control Glu Glu + DISS
(8mM) (8mM + 0.6μmol/L) (8mM + 6μmol/L) (8mM + 60μmol/L)
Bax 1 ± 0.249 2.317 ± 0.280## 2.081 ± 0.316 1.921 ± 0.458 1.597 ± 0.351∗∗
Bcl-2 1 ± 0.109 0.467 ± 0.025## 0.631 ± 0.018 0.743 ± 0.028 0.825 ± 0.016∗∗
##P<0.01, compared with normal cultures; ∗P<0.05, ∗∗P<0.01 compared with Glu alone group.
brain areas, which are believed to be involved in mood
disorders [11]. Additionally, it has been shown that chronic
treatment with antidepressants of diﬀerent mechanisms
reduces the glutamate release in rats [12, 13].
DISS is the active oligosaccharide ester component and
h a sb e e np r o v e nt oh a v ea n t i d e p r e s s a n t[ 5, 6], cerebral
protective, and cognition-improving eﬀects [14]. In the
present study, we demonstrated that cotreatment with DISS
protected SH-SY5Y neuronal cells against glutamate insult,
with maximal neuroprotection being observed at 60μmol/L.
Similarly, ﬂow cytometry detects apoptotic cells with
fragmented nuclei, which are also called sub-G1 cells. DISS
treatment signiﬁcantly reduced the apoptotic cells induced
by Glu. We also investigated whether DISS has any eﬀect
on the transcriptional level of Bax and Bcl-2 in Glu-treated
cells.ProapoptoticgeneBax,antiapoptoticgeneBcl-2mRNA
expression levels were measured by Real-Time PCR. It was
reported that Bax and Bcl-2, the two main members of
Bcl-2 family, play a key role in the mitochondrial pathway
of apoptosis. Bax has been implicated in promoting cellJournal of Biomedicine and Biotechnology 5
apoptosis,whereasBcl-2ininhibitingapoptosis[15,16].Our
results indicate that DISS provides neuroprotection partly by
the dramatic inhibition of bax overexpression induced by
glutamate and increasing antiapoptotic bcl-2 gene expres-
sion.
In summary, DISS could provide neuroprotection in
glutamate-induced cell injury model. The protective eﬀects
of DISS were related to modulating apoptosis-related gene
expression, by downregulating the synthesis of proapoptotic
Baxandupregulatingantiapoptoticbcl-2expression.Further
studies on the neuroprotection eﬀects of DISS in primary
neuronal cell injury model, mediated via MAPK-CREB-
BDNF/TrkB signaling pathway, are currently under way to
evaluatethedetailneuroprotectivemechanismoftherapeutic
eﬀorts of DISS.
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